Spanish Regulator Says Extensions: Binance EU License
Regulators in Spain are sending a clear message: there will be no extensions for the EU crypto licensing deadline. Th...
Which Dividend Etf Has The Lowest Expense Ratio 2024
Find out which Dividend Etf Has The Lowest Expense Ratio 2024 by reviewing fees, tracking error, and diversification to select a cost-efficient option.
27,604 articles
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Federal Civil Rights Agency Scraps 60-Year Diversity Rule
The federal civil rights agency voted 2-1 to terminate a 60-year-old workforce diversity reporting rule, a move that ...
Billionaire Philippe Laffont Just Shifts After CoreWeave
A tech-focused investor known for hunting winners, billionaire Philippe Laffont just rotated from a high-profile AI p...
Goldman Sachs Raises Price Targets on Tech Giants by 10%
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
Meet Artificial Intelligence (AI) Stocks Soaring in 2026
A standout AI infrastructure stock is delivering blistering earnings growth in 2026, reshaping the investing landscap...
Toyota's Challenging U.S. Business Spawn Maverick Rival
As toyota's challenging u.s. business tests the automaker, investors watch for strategies that could yield a Maverick...
Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Inflation Spiking Could Still Prompt Fed Policy Shifts
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...
Beaten-Down Stocks That Could Roar Back in June 2026
June 2026 opens with a handful of beaten-down stocks that could roar back as inflation cools and earnings beat expect...
Homebuilding Scale Emerges Fiduciary Priority for Boards
Boards of public homebuilders are treating scale as a fiduciary test, a shift highlighted by Berkshire Hathaway's Tay...
Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status